Accessibility
EasyRead Text Version
Showing 1 to 2 of 2 Results
Miyaoka T. et al. (2012)
Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.
BMC Psychiatry
12 pp. 215.
Read Abstract (New Window) Read Full (New Window)
Wake R. et al. (2013)
Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.
Journal of Child and Adolescent Psychopharmacology
23(5), pp. 329-336.
Read Abstract (New Window)
Publications | Publications Database | Search Publications
Rate This Page
Poor | Satisfactory | Good | Excellent
Print This Page / view All
Back to top
Your Rating: